This enterprise AI software provider reported a notable insider sale amid a year of sharp share price declines and changing ...

What Happened? A number of stocks fell in the morning session after reports of a ceasefire breach in the Middle East spiked ...

In the latest close session, C3.ai, Inc. (AI) was down 2.28% at $8.58. The stock fell short of the S&P 500, which registered a gain of 0.62% for the day. Meanwhile, the Dow experienced a rise of 0.58% ...

C3.ai (AI) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

C3.ai's management is extremely bullish on a recent agreement the company reached with Microsoft. The deal could lead to significant growth opportunities for C3.ai. What impact the agreement will have ...

C3.ai is operationally undervalued compared to Palantir and holds potential for good long-term returns, albeit likely not exceeding those of its competitor. Despite not being profitable yet, C3.ai’s ...

Complement component 3, often called C3, is an essential protein of the immune system. This protein plays a vital role in the body’s innate immune system, providing the first line of defense against ...